Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about JAK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
JAK is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, inhibits. Associated with ALS, Aging, Als. Connected to 853 entities in the SciDEX knowledge graph.
| Name | JAK |
| Summary | Companies developing JAK inhibitors and JAK-STAT pathway modulators for Parkinson's disease neuroinflammation and neuroprotection |
| Related Diseases | Inflammation, Als, Cancer, Tumor, Autoimmune |
| Related Pathways | Nf-Κb, Jak-Stat, Mapk |
Knowledge base pages for this entity
graph TD
JAK["JAK"]
JAK -->|"activates"| STAT3["STAT3"]
JAK -->|"regulates"| GENE_EXPRESSION["GENE_EXPRESSION"]
JAK -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
JAK -->|"target for"| Cardiovascular["Cardiovascular"]
JAK -->|"target for"| Inflammation["Inflammation"]
JAK -->|"target for"| Als["Als"]
JAK -->|"target for"| Cancer["Cancer"]
JAK -->|"target for"| Ms["Ms"]
IL6["IL6"] -->|"activates"| JAK
SOCS["SOCS"] -->|"inhibits"| JAK
STAT3 -->|"activates"| JAK
CD4["CD4"] -->|"target for"| JAK
BCL2["BCL2"] -->|"target for"| JAK
VIRAL_INFECTIONS["VIRAL INFECTIONS"] -->|"activates"| JAK
STAT2["STAT2"] -->|"inhibits"| JAK
MTOR["MTOR"] -->|"target for"| JAK| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Jak-Stat | activates | pathway | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| Mapk | activates | pathway | 1.00 |
| Jak-Stat | inhibits | pathway | 1.00 |
| Autoimmune | therapeutic_target | disease | 0.95 |
| Als | regulates | disease | 0.95 |
| Tumor | activates | disease | 0.95 |
| Tumor | inhibits | disease | 0.95 |
| Cancer | associated_with | disease | 0.95 |
| Cancer | regulates | disease | 0.95 |
| Als | treats | disease | 0.95 |
| STAT | activates | protein | 0.95 |
| Gene Expression | regulates | process | 0.95 |
| Ph-Like ALL | involved_in | disease | 0.95 |
| STAT3 | activates | protein | 0.90 |
| STAT3 | associated_with | gene | 0.90 |
| Chromatin | modulates | mechanism | 0.90 |
| Epigenome | modulates | mechanism | 0.90 |
| STAT3 | phosphorylates | protein | 0.90 |
| JAK-STAT signaling | participates_in | pathway | 0.90 |
| NF-kB signaling | participates_in | pathway | 0.90 |
| neural stem cells | activates | cell_type | 0.90 |
| Apoptosis | regulates | pathway | 0.90 |
| Differentiation | regulates | pathway | 0.90 |
| Metastasis | therapeutic_target | pathway | 0.90 |
| Differentiation | therapeutic_target | pathway | 0.90 |
| Cardiovascular | therapeutic_target | disease | 0.85 |
| Neuroinflammation | activates | disease | 0.85 |
| Alzheimer | therapeutic_target | disease | 0.85 |
| Tumor | regulates | disease | 0.85 |
| Neurodegeneration | activates | disease | 0.85 |
| Neuroinflammation | therapeutic_target | disease | 0.85 |
| Inflammation | causes | disease | 0.85 |
| Malignant Cell Survival | associated_with | phenotype | 0.85 |
| Malignant Cell Proliferation | associated_with | phenotype | 0.85 |
| TGF-beta signaling | participates_in | pathway | 0.80 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.80 |
| MAPK signaling | participates_in | pathway | 0.80 |
| microglia | expressed_in | cell_type | 0.80 |
| epigenetic regulation | participates_in | pathway | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| INFLAMMATION | activates | gene | 1.00 |
| STAT3 | therapeutic_target | gene | 1.00 |
| IL-6 | therapeutic_target | gene | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| ERK | activates | gene | 1.00 |
| IL-6 | activates | gene | 1.00 |
| CYTOKINES | inhibits | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| NF-KB | associated_with | gene | 0.98 |
| CANCER | regulates | gene | 0.90 |
| CANCER | activates | gene | 0.90 |
| INFLAMMATION | inhibits | gene | 0.90 |
| CYTOKINES | therapeutic_target | gene | 0.90 |
| NF-ΚB | activates | gene | 0.90 |
| INFLAMMATION | regulates | gene | 0.90 |
| RAS | activates | gene | 0.90 |
| IL6 | activates | protein | 0.87 |
| IL-6 | associated_with | gene | 0.82 |
| SOCS | inhibits | protein | 0.80 |
| Polyphenols | inhibits | compound | 0.80 |
| CANCER | associated_with | gene | 0.80 |
| CYTOKINES | activates | gene | 0.80 |
| GENES | inhibits | gene | 0.80 |
| AMPK | activates | gene | 0.80 |
| OXIDATIVE STRESS | activates | gene | 0.80 |
| CANCER | inhibits | disease | 0.80 |
| AKT | regulates | gene | 0.80 |
| TNF | inhibits | gene | 0.80 |
| IL-6 | inhibits | gene | 0.80 |
| TNF-Α | inhibits | gene | 0.80 |
| PI3K | contributes_to | gene | 0.80 |
| AKT | contributes_to | gene | 0.80 |
| GENES | activates | gene | 0.80 |
| INFLAMMATION | causes | gene | 0.80 |
| TNF-Α | activates | gene | 0.80 |
| STAT3 | activates | protein | 0.74 |
| TNF | associated_with | gene | 0.74 |
| AMYLOID | associated_with | protein | 0.74 |
| ERK | therapeutic_target | gene | 0.70 |
| IL6 | therapeutic_target | gene | 0.70 |
| MICRORNAS | regulates | gene | 0.70 |
| NRF2 | inhibits | gene | 0.70 |
| PROINFLAMMATORY CYTOKINES | inhibits | gene | 0.70 |
| APOPTOSIS | therapeutic_target | gene | 0.70 |
| VEGFA | therapeutic_target | gene | 0.70 |
| NF-ΚB | regulates | gene | 0.70 |
| BRAIN INFLAMMATION | regulates | gene | 0.70 |
| TNF | therapeutic_target | gene | 0.70 |
| NF-ΚB | contributes_to | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||